Cargando…

Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine

BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bijian, K, Lougheed, C, Su, J, Xu, B, Yu, H, Wu, J H, Riccio, K, Alaoui-Jamali, M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844920/
https://www.ncbi.nlm.nih.gov/pubmed/24169345
http://dx.doi.org/10.1038/bjc.2013.675
_version_ 1782293263976235008
author Bijian, K
Lougheed, C
Su, J
Xu, B
Yu, H
Wu, J H
Riccio, K
Alaoui-Jamali, M A
author_facet Bijian, K
Lougheed, C
Su, J
Xu, B
Yu, H
Wu, J H
Riccio, K
Alaoui-Jamali, M A
author_sort Bijian, K
collection PubMed
description BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cancer cell invasion in in vitro and in vivo conditions. METHODS: Live imaging and immunofluorescence assays were used to investigate FA turnover in breast cancer cells. Biochemical studies were used to investigate the impact of reversine on FA signalling and turnover. In vivo activity was investigated using orthotopic breast cancer mouse models. RESULTS: Accelerated FA disassembly from plasma membrane protrusions was observed in invasive compared with non-invasive breast cancer cells or non-immortalised mammary epithelial cells. Reversine significantly inhibited FA disassembly leading to stable FAs, which was associated with reduced cell motility and invasion. The inhibitory effect of reversine on FA turnover accounted for a large part on its capacity to interfere with FAK function on regulating its downstream targets. In orthotopic breast cancer mouse models, reversine revealed a potent inhibitory activity on tumour progression to metastasis. CONCLUSION: These results support the utility of targeting FA turnover as a therapeutic approach for invasive breast cancer.
format Online
Article
Text
id pubmed-3844920
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-38449202014-11-26 Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine Bijian, K Lougheed, C Su, J Xu, B Yu, H Wu, J H Riccio, K Alaoui-Jamali, M A Br J Cancer Translational Therapeutics BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cancer cell invasion in in vitro and in vivo conditions. METHODS: Live imaging and immunofluorescence assays were used to investigate FA turnover in breast cancer cells. Biochemical studies were used to investigate the impact of reversine on FA signalling and turnover. In vivo activity was investigated using orthotopic breast cancer mouse models. RESULTS: Accelerated FA disassembly from plasma membrane protrusions was observed in invasive compared with non-invasive breast cancer cells or non-immortalised mammary epithelial cells. Reversine significantly inhibited FA disassembly leading to stable FAs, which was associated with reduced cell motility and invasion. The inhibitory effect of reversine on FA turnover accounted for a large part on its capacity to interfere with FAK function on regulating its downstream targets. In orthotopic breast cancer mouse models, reversine revealed a potent inhibitory activity on tumour progression to metastasis. CONCLUSION: These results support the utility of targeting FA turnover as a therapeutic approach for invasive breast cancer. Nature Publishing Group 2013-11-26 2013-10-29 /pmc/articles/PMC3844920/ /pubmed/24169345 http://dx.doi.org/10.1038/bjc.2013.675 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Translational Therapeutics
Bijian, K
Lougheed, C
Su, J
Xu, B
Yu, H
Wu, J H
Riccio, K
Alaoui-Jamali, M A
Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title_full Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title_fullStr Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title_full_unstemmed Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title_short Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
title_sort targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844920/
https://www.ncbi.nlm.nih.gov/pubmed/24169345
http://dx.doi.org/10.1038/bjc.2013.675
work_keys_str_mv AT bijiank targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT lougheedc targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT suj targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT xub targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT yuh targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT wujh targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT ricciok targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine
AT alaouijamalima targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine